{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:10:55Z","timestamp":1782407455388,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The <jats:italic>Orthopoxvirus<\/jats:italic> genus, especially variola virus (VARV), monkeypox virus (MPXV), remains a significant public health threat worldwide. The development of therapeutic antibodies against orthopoxviruses is largely hampered by the high cost of antibody engineering and manufacturing processes. mRNA-encoded antibodies have emerged as a powerful and universal platform for rapid antibody production. Herein, by using the established lipid nanoparticle (LNP)-encapsulated mRNA platform, we constructed four mRNA combinations that encode monoclonal antibodies with broad neutralization activities against orthopoxviruses. In vivo characterization demonstrated that a single intravenous injection of each LNP-encapsulated mRNA antibody in mice resulted in the rapid production of neutralizing antibodies. More importantly, mRNA antibody treatments showed significant protection from weight loss and mortality in the vaccinia virus (VACV) lethal challenge mouse model, and a unique mRNA antibody cocktail, Mix2a, exhibited superior in vivo protection by targeting both intracellular mature virus (IMV)-form and extracellular enveloped virus (EEV)-form viruses. In summary, our results demonstrate the proof-of-concept production of orthopoxvirus antibodies via the LNP-mRNA platform, highlighting the great potential of tailored mRNA antibody combinations as a universal strategy to combat orthopoxvirus as well as other emerging viruses.<\/jats:p>","DOI":"10.1038\/s41392-024-01766-8","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:02:12Z","timestamp":1711497732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses"],"prefix":"10.1038","volume":"9","author":[{"given":"Hang","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo-Qun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Xing","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3827-5969","authenticated-orcid":false,"given":"Dong-Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-1430","authenticated-orcid":false,"given":"Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2306-1039","authenticated-orcid":false,"given":"Yong-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-2807","authenticated-orcid":false,"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"1766_CR1","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3390\/v14091894","volume":"14","author":"G Tiecco","year":"2022","unstructured":"Tiecco, G. et al. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From? Viruses 14, 1894 (2022).","journal-title":"Viruses"},{"key":"1766_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw8977","volume":"369","author":"B M\u00fchlemann","year":"2020","unstructured":"M\u00fchlemann, B. et al. Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age. Science 369, eaaw8977 (2020).","journal-title":"Science"},{"key":"1766_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/QCO.0b013e3282f44c74","volume":"21","author":"RM Vorou","year":"2008","unstructured":"Vorou, R. M., Papavassiliou, V. G. & Pierroutsakos, I. N. Cowpox virus infection: an emerging health threat. Curr. Opin. Infect. Dis. 21, 153\u2013156 (2008).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1766_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3201\/eid1307.061404","volume":"13","author":"GS Trindade","year":"2007","unstructured":"Trindade, G. S., Emerson, G. L., Carroll, D. S., Kroon, E. G. & Damon, I. K. Brazilian vaccinia viruses and their origins. Emerg. Infect. Dis. 13, 965\u2013972 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"1766_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1128\/JVI.02089-12","volume":"87","author":"MB Townsend","year":"2013","unstructured":"Townsend, M. B. et al. Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations. J. Virol. 87, 900\u2013911 (2013).","journal-title":"J. Virol."},{"key":"1766_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/d41586-022-01421-8","volume":"606","author":"M Kozlov","year":"2022","unstructured":"Kozlov, M. Monkeypox goes global: why scientists are on alert. Nature 606, 15\u201316 (2022).","journal-title":"Nature"},{"key":"1766_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/ZOONOSES-2022-0046","volume":"3","author":"MX Sun","year":"2023","unstructured":"Sun, M. X., Huang, X. Y. & Qin, C. F. Novel Clinical and Genomic Signatures of the 2022 Monkeypox Virus. Zoonoses 3, 1\u20134 (2023).","journal-title":"Zoonoses"},{"key":"1766_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2023.101102","volume":"52","author":"H Guan","year":"2023","unstructured":"Guan, H. et al. Emergence, phylogeography, and adaptive evolution of mpox virus. N. Microbes N. Infect. 52, 101102 (2023).","journal-title":"N. Microbes N. Infect."},{"key":"1766_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41392-022-01181-x","volume":"7","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Li, M. & Fan, H. The monkeypox outbreak in 2022: adaptive evolution associated with APOBEC3 may account for. Signal Transduct. Target Ther. 7, 323 (2022).","journal-title":"Signal Transduct. Target Ther."},{"issue":"Suppl 4","key":"1766_CR10","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2011.05.037","volume":"29","author":"SN Shchelkunov","year":"2011","unstructured":"Shchelkunov, S. N. Emergence and reemergence of smallpox: the need for development of a new generation smallpox vaccine. Vaccine 29(Suppl 4), D49\u2013D53 (2011).","journal-title":"Vaccine"},{"key":"1766_CR11","doi-asserted-by":"publisher","first-page":"e01683","DOI":"10.1128\/AAC.01683-19","volume":"64","author":"D Delaune","year":"2020","unstructured":"Delaune, D. & Iseni, F. Drug Development against Smallpox: Present and Future. Antimicrob. Agents Chemother. 64, e01683\u201301619 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1766_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11427-023-2378-x","volume":"66","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity. Sci. China Life Sci. 66, 1\u201313 (2023).","journal-title":"Sci. China Life Sci."},{"key":"1766_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3540","volume":"15","author":"AW Freyn","year":"2023","unstructured":"Freyn, A. W. et al. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci. Transl. Med. 15, eadg3540 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1766_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"FM Lum","year":"2022","unstructured":"Lum, F. M. et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat. Rev. Immunol. 22, 597\u2013613 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1766_CR15","doi-asserted-by":"publisher","first-page":"102528","DOI":"10.1016\/j.tmaid.2022.102528","volume":"52","author":"E De Clercq","year":"2023","unstructured":"De Clercq, E., Jiang, Y. & Li, G. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf. Travel Med Infect. Dis. 52, 102528 (2023).","journal-title":"Travel Med Infect. Dis."},{"key":"1766_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","volume":"10","author":"R Wittek","year":"2006","unstructured":"Wittek, R. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J. Infect. Dis. 10, 193\u2013201 (2006).","journal-title":"Int J. Infect. Dis."},{"key":"1766_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","volume":"83","author":"JC Ram\u00edrez","year":"2002","unstructured":"Ram\u00edrez, J. C., Tapia, E. & Esteban, M. Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions. J. Gen. Virol. 83, 1059\u20131067 (2002).","journal-title":"J. Gen. Virol."},{"key":"1766_CR18","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1128\/JVI.00906-07","volume":"81","author":"Z Chen","year":"2007","unstructured":"Chen, Z. et al. Characterization of chimpanzee\/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. J. Virol. 81, 8989\u20138995 (2007).","journal-title":"J. Virol."},{"key":"1766_CR19","doi-asserted-by":"publisher","first-page":"e0006581","DOI":"10.1371\/journal.pntd.0006581","volume":"12","author":"EM Mucker","year":"2018","unstructured":"Mucker, E. M. et al. Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS Negl. Trop. Dis. 12, e0006581 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1766_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.icb.7100118","volume":"86","author":"V Panchanathan","year":"2008","unstructured":"Panchanathan, V., Chaudhri, G. & Karupiah, G. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol. 86, 80\u201386 (2008).","journal-title":"Immunol. Cell Biol."},{"key":"1766_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","volume":"239","author":"B Moss","year":"2011","unstructured":"Moss, B. Smallpox vaccines: targets of protective immunity. Immunol. Rev. 239, 8\u201326 (2011).","journal-title":"Immunol. Rev."},{"key":"1766_CR22","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1073\/pnas.0510598103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen, Z. et al. Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proc. Natl Acad. Sci. USA 103, 1882\u20131887 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1766_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2223669","volume":"12","author":"M Li","year":"2023","unstructured":"Li, M. et al. Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus. Emerg. Microbes Infect. 12, 2223669 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"1766_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1128\/jvi.56.2.482-488.1985","volume":"56","author":"JF Rodriguez","year":"1985","unstructured":"Rodriguez, J. F., Janeczko, R. & Esteban, M. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J. Virol. 56, 482\u2013488 (1985).","journal-title":"J. Virol."},{"key":"1766_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","volume":"167","author":"I Gilchuk","year":"2016","unstructured":"Gilchuk, I. et al. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell 167, 684\u2013694.e689 (2016).","journal-title":"Cell"},{"key":"1766_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1804-8","volume":"17","author":"L Van Hoecke","year":"2019","unstructured":"Van Hoecke, L. & Roose, K. How mRNA therapeutics are entering the monoclonal antibody field. J. Transl. Med. 17, 54 (2019).","journal-title":"J. Transl. Med"},{"key":"1766_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/vaccines9020108","volume":"9","author":"CE Deal","year":"2021","unstructured":"Deal, C. E., Carfi, A. & Plante, O. J. Advancements in mRNA Encoded Antibodies for Passive Immunotherapy. Vaccines 9, 108 (2021).","journal-title":"Vaccines"},{"key":"1766_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/viro.2002.1446","volume":"297","author":"SN Shchelkunov","year":"2002","unstructured":"Shchelkunov, S. N. et al. Analysis of the monkeypox virus genome. Virology 297, 172\u2013194 (2002).","journal-title":"Virology"},{"key":"1766_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41422-022-00630-0","volume":"32","author":"YQ Deng","year":"2022","unstructured":"Deng, Y. Q. et al. Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters. Cell Res. 32, 375\u2013382 (2022).","journal-title":"Cell Res."},{"key":"1766_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04553-1","volume":"21","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y., Gan, L., Ke, D., Chen, Q. & Fu, Y. Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy. J. Transl. Med. 21, 693 (2023).","journal-title":"J. Transl. Med."},{"key":"1766_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.omtn.2022.05.025","volume":"28","author":"EM Mucker","year":"2022","unstructured":"Mucker, E. M., Thiele-Suess, C., Baumhof, P. & Hooper, J. W. Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits. Mol. Ther. Nucleic Acids 28, 847\u2013858 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1766_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","volume":"8","author":"Y Sang","year":"2023","unstructured":"Sang, Y. et al. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal Transduct. Target Ther. 8, 172 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"1766_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2204151","volume":"12","author":"J Zeng","year":"2023","unstructured":"Zeng, J. et al. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge. Emerg. Microbes Infect. 12, 2204151 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"1766_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41422-023-00792-5","volume":"33","author":"Z Fang","year":"2023","unstructured":"Fang, Z. et al. Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens. Cell Res. 33, 407\u2013410 (2023).","journal-title":"Cell Res"},{"key":"1766_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41587-x","volume":"14","author":"AD Otter","year":"2023","unstructured":"Otter, A. D. et al. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals. Nat. Commun. 14, 5948 (2023).","journal-title":"Nat. Commun."},{"key":"1766_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S1473-3099(23)00270-0","volume":"23","author":"SN Ladhani","year":"2023","unstructured":"Ladhani, S. N. et al. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response. Lancet Infect. Dis. 23, 1042\u20131050 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"1766_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02872-0","volume":"21","author":"Y Feng","year":"2023","unstructured":"Feng, Y. et al. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population. BMC Med. 21, 183 (2023).","journal-title":"BMC Med."},{"key":"1766_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28763","volume":"95","author":"J Dai","year":"2023","unstructured":"Dai, J. et al. Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV-1 from Guangzhou, China. J. Med. Virol. 95, e28763 (2023).","journal-title":"J. Med. Virol."},{"key":"1766_CR39","doi-asserted-by":"publisher","first-page":"e1005148","DOI":"10.1371\/journal.ppat.1005148","volume":"11","author":"MH Matho","year":"2015","unstructured":"Matho, M. H. et al. Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer. PLoS Pathog. 11, e1005148 (2015).","journal-title":"PLoS Pathog."},{"key":"1766_CR40","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/vaccines10071084","volume":"10","author":"X Gu","year":"2022","unstructured":"Gu, X. et al. Protective Human Anti-Poxvirus Monoclonal Antibodies Are Generated from Rare Memory B Cells Isolated by Multicolor Antigen Tetramers. Vaccines 10, 1084 (2022).","journal-title":"Vaccines"},{"key":"1766_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41628-5","volume":"14","author":"F Hou","year":"2023","unstructured":"Hou, F. et al. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat. Commun. 14, 5925 (2023).","journal-title":"Nat. Commun."},{"key":"1766_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","volume":"25","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Rational design of a \u2018two-in-one\u2019 immunogen DAM drives potent immune response against mpox virus. Nat. Immunol. 25, 307\u2013315 (2024).","journal-title":"Nat. Immunol."},{"key":"1766_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675655","volume":"12","author":"ML Fern\u00e1ndez-Quintero","year":"2021","unstructured":"Fern\u00e1ndez-Quintero, M. L. et al. Germline-Dependent Antibody Paratope States and Pairing Specific V(H)-V(L) Interface Dynamics. Front Immunol. 12, 675655 (2021).","journal-title":"Front Immunol."},{"key":"1766_CR44","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1016\/j.xphs.2021.04.010","volume":"110","author":"M Cao","year":"2021","unstructured":"Cao, M. et al. Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody. J. Pharm. Sci. 110, 2904\u20132915 (2021).","journal-title":"J. Pharm. Sci."},{"key":"1766_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.virol.2020.02.004","volume":"544","author":"EM Mucker","year":"2020","unstructured":"Mucker, E. M., Lindquist, M. & Hooper, J. W. Particle-specific neutralizing activity of a monoclonal antibody targeting the poxvirus A33 protein reveals differences between cell associated and extracellular enveloped virions. Virology 544, 42\u201354 (2020).","journal-title":"Virology"},{"key":"1766_CR46","doi-asserted-by":"publisher","first-page":"e0131742","DOI":"10.1371\/journal.pone.0131742","volume":"10","author":"EM Mucker","year":"2015","unstructured":"Mucker, E. M. et al. Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease. PLoS One 10, e0131742 (2015).","journal-title":"PLoS One"},{"key":"1766_CR47","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","volume":"175","author":"M Fang","year":"2005","unstructured":"Fang, M. & Sigal, L. J. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 175, 6829\u20136836 (2005).","journal-title":"J. Immunol."},{"key":"1766_CR48","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","volume":"182","author":"NN Zhang","year":"2020","unstructured":"Zhang, N. N. et al. A Thermostable mRNA Vaccine against COVID-19. Cell 182, 1271\u20131283.e1216 (2020).","journal-title":"Cell"},{"key":"1766_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2192815","volume":"12","author":"RR Zhang","year":"2023","unstructured":"Zhang, R. R. et al. Rational development of multicomponent mRNA vaccine candidates against mpox. Emerg. Microbes Infect. 12, 2192815 (2023).","journal-title":"Emerg. Microbes Infect."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01766-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:02:50Z","timestamp":1711497770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01766-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1038\/s41392-024-01766-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.F.Q., Y.Q.D., H.C., S.Q.Z., R.Y.C., and X.X.S. have filed patents related to the finding reported in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}